Ben Lasko

Cause of Death and Predictors of All‐Cause Mortality in Anticoagulated Patients With Nonvalvular Atrial Fibrillation: Data From ROCKET AF

Sean D. Pokorney, Jonathan P. Piccini, Susanna R. Stevens et al. · Journal of the American Heart Association · 2016 · 196 citations · Full text

Alvimopan, a peripherally acting mu-opioid receptor (PAM-OR) antagonist for the treatment of opioid-induced bowel dysfunction: Results from a randomized, double-blind, placebo-controlled, dose-finding study in subjects taking opioids for chronic non-cancer pain

Lynn R. Webster, Jan Peter Jansen, John F. Peppin et al. · Pain · 2008 · 144 citations

Dose-finding Study, Opioid Epidemic, Spontaneous Bowel Movements +22

A Randomized, Placebo-Controlled Phase 3 Trial (Study SB-767905/012) of Alvimopan for Opioid-Induced Bowel Dysfunction in Patients With Non-Cancer Pain

Jan‐Peter Jansen, Daniel Lorch, John Langan et al. · Journal of Pain · 2011 · 66 citations

Opioid-induced Bowel Dysfunction, Oncology, Placebo-controlled Phase 3 +14

Effects of taspoglutide on glycemic control and body weight in obese patients with type 2 diabetes (T‐emerge 7 study)

Priscilla Hollander, Ben Lasko, Anthony Barnett et al. · Obesity · 2013 · 27 citations

Extended-release tramadol/paracetamol in moderate-to-severe pain: a randomized, placebo-controlled study in patients with acute low back pain

Ben Lasko, Randy J. Levitt, K. D. Rainsford et al. · Current Medical Research and Opinion · 2012 · 20 citations